Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Cancer Genomics & Proteomics
    • Anticancer Research
    • In Vivo

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Cancer Genomics & Proteomics
  • Other Publications
    • Cancer Genomics & Proteomics
    • Anticancer Research
    • In Vivo
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Cancer Genomics & Proteomics

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Visit iiar on Facebook
  • Follow us on Linkedin

Index by author

November-December 2024; Volume 21,Issue 6
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

  1. Baba, MOTOI

    1. Open Access
      Serum Exosomes Expressing CD9, CD63 and HER2 From Breast-Cancer Patients Decreased After Surgery of the Primary Tumor: A Potential Biomarker of Tumor Burden
      SACHIKO INUBUSHI, TOMONARI KUNIHISA, MARINA KUNIYASU, SHOTARO INOUE, MAYUKO YAMAMOTO, YUJI YAMASHITA, MAYUKO MIKI, SACHIKO MIZUMOTO, MOTOI BABA, ROBERT M. HOFFMAN and HIROKAZU TANINO
      Cancer Genomics & Proteomics November 2024, 21 (6) 580-584; DOI: https://doi.org/10.21873/cgp.20474
  2. Bouvet, MICHAEL

    1. Open Access
      Extensive DNA Damage and Loss of Cell Viability Occur Synergistically With the Combination of Recombinant Methioninase and Paclitaxel on Pancreatic Cancer Cells which Report DNA-Damage Response in Real Time
      SEI MORINAGA, QINGHONG HAN, KOHEI MIZUTA, BYUNG MO KANG, MOTOKAZU SATO, MICHAEL BOUVET, NORIO YAMAMOTO, KATSUHIRO HAYASHI, HIROAKI KIMURA, SHINJI MIWA, KENTARO IGARASHI, TAKASHI HIGUCHI, HIROYUKI TSUCHIYA, SATORU DEMURA and ROBERT M. HOFFMAN
      Cancer Genomics & Proteomics November 2024, 21 (6) 585-590; DOI: https://doi.org/10.21873/cgp.20475
  3. Chae, YEONSOO

    1. Open Access
      Gene Expression Profiling Regulated by lncRNA H19 Using Bioinformatic Analyses in Glioma Cell Lines
      YEONSOO CHAE, JUNGWOOK ROH, MIJUNG IM, WONYI JANG, BOSEONG KIM, JIHOON KANG, BUHYUN YOUN and WANYEON KIM
      Cancer Genomics & Proteomics November 2024, 21 (6) 608-621; DOI: https://doi.org/10.21873/cgp.20477
  4. Chen, CHIN-YING

    1. Open Access
      Cordycepin Activates Autophagy to Suppress FGF9-induced TM3 Mouse Leydig Progenitor Cell Proliferation
      SU-ZHEN WU, YU-YAN LAN, CHIN-YING CHEN, LI-CHING CHEN and BU-MIIN HUANG
      Cancer Genomics & Proteomics November 2024, 21 (6) 630-644; DOI: https://doi.org/10.21873/cgp.20479
  5. Chen, LI-CHING

    1. Open Access
      Cordycepin Activates Autophagy to Suppress FGF9-induced TM3 Mouse Leydig Progenitor Cell Proliferation
      SU-ZHEN WU, YU-YAN LAN, CHIN-YING CHEN, LI-CHING CHEN and BU-MIIN HUANG
      Cancer Genomics & Proteomics November 2024, 21 (6) 630-644; DOI: https://doi.org/10.21873/cgp.20479
  6. Chung, JAE-WOOK

    1. Open Access
      Comparative Proteomics of ccRCC Cell Lines to Identify Kidney Cancer Progression Factors
      JUHEE PARK, HYUNCHAE SIM, EUN HYE LEE, BUM SOO KIM, JAE-WOOK CHUNG, YUN-SOK HA, TAE GYUN KWON, SANGKYU LEE and JUN NYUNG LEE
      Cancer Genomics & Proteomics November 2024, 21 (6) 645-652; DOI: https://doi.org/10.21873/cgp.20480
  7. Demura, SATORU

    1. Open Access
      Extensive DNA Damage and Loss of Cell Viability Occur Synergistically With the Combination of Recombinant Methioninase and Paclitaxel on Pancreatic Cancer Cells which Report DNA-Damage Response in Real Time
      SEI MORINAGA, QINGHONG HAN, KOHEI MIZUTA, BYUNG MO KANG, MOTOKAZU SATO, MICHAEL BOUVET, NORIO YAMAMOTO, KATSUHIRO HAYASHI, HIROAKI KIMURA, SHINJI MIWA, KENTARO IGARASHI, TAKASHI HIGUCHI, HIROYUKI TSUCHIYA, SATORU DEMURA and ROBERT M. HOFFMAN
      Cancer Genomics & Proteomics November 2024, 21 (6) 585-590; DOI: https://doi.org/10.21873/cgp.20475
  8. Doelker, TAMMY

    1. Open Access
      Suppressing Expression of SERPINE1/PAI1 Through Activation of GPER1 Reduces Progression of Vulvar Carcinoma
      TAMMY DOELKER, JULIA GALLWAS and CARSTEN GRÜNDKER
      Cancer Genomics & Proteomics November 2024, 21 (6) 566-579; DOI: https://doi.org/10.21873/cgp.20473
  9. Gallwas, JULIA

    1. Open Access
      Suppressing Expression of SERPINE1/PAI1 Through Activation of GPER1 Reduces Progression of Vulvar Carcinoma
      TAMMY DOELKER, JULIA GALLWAS and CARSTEN GRÜNDKER
      Cancer Genomics & Proteomics November 2024, 21 (6) 566-579; DOI: https://doi.org/10.21873/cgp.20473
  10. Goto, TAKURO

    1. Open Access
      GULP1 as a Downstream Effector of the Estrogen Receptor-β Modulates Cisplatin Sensitivity in Bladder Cancer
      TOMOYUKI TATENUMA, TAKUO MATSUKAWA, TAKURO GOTO, GUIYANG JIANG, ADHYA SHARMA, MOHAMMAD AMIN ELAHI NAJAFI, YUKI TERAMOTO and HIROSHI MIYAMOTO
      Cancer Genomics & Proteomics November 2024, 21 (6) 557-565; DOI: https://doi.org/10.21873/cgp.20472
« Previous (Pages : 1 2 3 4 5 6 ... 8) Next »
Back to top
PreviousNext

In this issue

Cancer Genomics - Proteomics: 21 (6)
Cancer Genomics & Proteomics
Vol. 21, Issue 6
November-December 2024
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)

Issue highlights

  • GULP1 as a Downstream Effector of the Estrogen Receptor-β Modulates Cisplatin Sensitivity in Bladder Cancer
  • Suppressing Expression of SERPINE1/PAI1 Through Activation of GPER1 Reduces Progression of Vulvar Carcinoma
  • Serum Exosomes Expressing CD9, CD63 and HER2 From Breast-Cancer Patients Decreased After Surgery of the Primary Tumor: A Potential Biomarker of Tumor Burden
  • GD2 in Breast Cancer: A Potential Biomarker and Therapeutic Target
  • Impact of Hypoxia and the Levels of Transcription Factor HIF-1α and JMJD1A on Epithelial-Mesenchymal Transition in Head and Neck Squamous Cell Carcinoma Cell Lines
Sign up for alerts
  • Top Topics
  • Most Cited
  • Most Read
Loading
Breast Cancer Metastasis
Applications of Support Vector Machine (SVM) Learning in Cancer Genomics
Cancer-related Issues of CD147
Long Non-coding RNAs and their Role in Metastasis
The Multiple Roles of Exosomes in Metastasis
Screening for Epigenetically Masked Genes in Colorectal Cancer Using 5-Aza-2’-deoxycytidine, Microarray and Gene Expression Profile
Cancer & Genome Proteomics

© 2026 Cancer Genomics & Proteomics

Powered by HighWire